Fig. 1: Metabolic features and pathways associated with clinical AD, biomarker-supported AD and plasma biomarkers.
From: Lysophosphatidylcholines are associated with amyloidosis in early stages of Alzheimer’s disease
a, Modified Miami plot shows features with positive β values above the zero line and those with negative β values below the zero line. The dark blue points indicate features with FDR q-value < 0.05 for data obtained for each column (C18 and HILIC). NS, not significant. b, Metabolic pathways, with Fisher’s exact test P < 0.05, enriched by features nominally associated with the clinical AD, biomarker-supported AD and plasma biomarker.
